• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

巨核细胞评估在骨髓细胞学中的作用。

The Role of Megakaryocyte Assessment in Bone Marrow Cytology.

作者信息

Błocka-Gumowska Monika, Hus Iwona, Szymczyk Agnieszka

机构信息

Laboratory Diagnostics Centre, National Medical Institute of the Ministry of Interior and Administration, Wołoska 137 Str., 02-507 Warsaw, Poland.

Department of Hematology, National Medical Institute of the Ministry of Interior and Administration, Wołoska 137 Str., 02-507 Warsaw, Poland.

出版信息

J Clin Med. 2025 Apr 14;14(8):2681. doi: 10.3390/jcm14082681.

DOI:10.3390/jcm14082681
PMID:40283511
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC12027952/
Abstract

Despite the progress made in recent years in hematological diagnostics, cytological assessment of bone marrow, including the assessment of megakaryocytes, is still an important element of the diagnostic process. It is one of the most accurate methods for detecting even minor abnormalities, which is often superior to histopathological examination in this respect. Although, according to current recommendations, megakaryocytes are not included in the total percentage formula of the myelogram, the assessment of platelet function, morphological features, and quantitative disorders allows for the direction of further diagnostic process. In this article, we present the principles of assessing megakaryocytes in a bone marrow aspirate smear. We also characterize normal megakaryocytes at various stages of megakaryopoiesis, atypical megakaryocytes in pathological and physiological conditions, and cells with a similar morphology to megakaryocytes.

摘要

尽管近年来血液学诊断取得了进展,但骨髓的细胞学评估,包括巨核细胞的评估,仍然是诊断过程中的一个重要环节。它是检测即使是微小异常的最准确方法之一,在这方面通常优于组织病理学检查。虽然根据目前的建议,巨核细胞不包括在骨髓细胞分类计数的总百分比公式中,但对血小板功能、形态特征和数量紊乱的评估有助于指导进一步的诊断过程。在本文中,我们介绍了骨髓穿刺涂片巨核细胞评估的原则。我们还描述了巨核细胞生成各阶段的正常巨核细胞、病理和生理条件下的非典型巨核细胞以及形态与巨核细胞相似的细胞。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/898f/12027952/7ca330cfcd01/jcm-14-02681-g008.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/898f/12027952/852494444be1/jcm-14-02681-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/898f/12027952/fbe8cff1b1e3/jcm-14-02681-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/898f/12027952/b92efc655781/jcm-14-02681-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/898f/12027952/00da1f5bc12e/jcm-14-02681-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/898f/12027952/b0e7477f34cb/jcm-14-02681-g006.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/898f/12027952/598ac59bb14e/jcm-14-02681-g007.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/898f/12027952/7ca330cfcd01/jcm-14-02681-g008.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/898f/12027952/852494444be1/jcm-14-02681-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/898f/12027952/fbe8cff1b1e3/jcm-14-02681-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/898f/12027952/b92efc655781/jcm-14-02681-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/898f/12027952/00da1f5bc12e/jcm-14-02681-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/898f/12027952/b0e7477f34cb/jcm-14-02681-g006.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/898f/12027952/598ac59bb14e/jcm-14-02681-g007.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/898f/12027952/7ca330cfcd01/jcm-14-02681-g008.jpg

相似文献

1
The Role of Megakaryocyte Assessment in Bone Marrow Cytology.巨核细胞评估在骨髓细胞学中的作用。
J Clin Med. 2025 Apr 14;14(8):2681. doi: 10.3390/jcm14082681.
2
Hypercholesterolemia impairs megakaryopoiesis and platelet production in scavenger receptor BI knockout mice.高胆固醇血症损害清道夫受体 BI 基因敲除小鼠的巨核细胞生成和血小板生成。
Atherosclerosis. 2019 Mar;282:176-182. doi: 10.1016/j.atherosclerosis.2018.09.019. Epub 2018 Sep 22.
3
In the Era of Molecular Pathology, the Role of Morphological Changes in Megakaryocytes in Bone Marrow Aspiration in Cases of Isolated Thrombocytopenia.在分子病理学时代,孤立性血小板减少症病例中骨髓穿刺巨核细胞形态学改变的作用
Cureus. 2024 Nov 24;16(11):e74336. doi: 10.7759/cureus.74336. eCollection 2024 Nov.
4
Diagnosis, pathogenesis and treatment of the myeloproliferative disorders essential thrombocythemia, polycythemia vera and essential megakaryocytic granulocytic metaplasia and myelofibrosis.骨髓增殖性疾病(原发性血小板增多症、真性红细胞增多症、原发性巨核细胞粒细胞化生及骨髓纤维化)的诊断、发病机制与治疗
Neth J Med. 1999 Feb;54(2):46-62. doi: 10.1016/s0300-2977(98)00143-0.
5
GATA1 insufficiencies in dysmegakaryopoiesis of myelodysplastic syndromes/neoplasms.骨髓增生异常综合征/肿瘤巨核细胞生成异常中的GATA1功能不足。
Pathol Res Pract. 2025 May;269:155930. doi: 10.1016/j.prp.2025.155930. Epub 2025 Mar 29.
6
Investigation of megakaryocyte apoptosis in children with acute and chronic idiopathic thrombocytopenic purpura.急性和慢性特发性血小板减少性紫癜患儿巨核细胞凋亡的研究。
Eur J Haematol. 2003 Jun;70(6):347-52. doi: 10.1034/j.1600-0609.2003.00069.x.
7
[Comparative study on bone marrow megakaryocytes in children with thrombocytopenic purpura, aplastic anemia and myelodysplastic syndrome].血小板减少性紫癜、再生障碍性贫血和骨髓增生异常综合征患儿骨髓巨核细胞的比较研究
Zhonghua Er Ke Za Zhi. 2005 Mar;43(3):183-7.
8
Immune attack on megakaryocytes in immune thrombocytopenia.免疫性血小板减少症中免疫对巨核细胞的攻击。
Res Pract Thromb Haemost. 2024 Mar 14;8(1):102345. doi: 10.1016/j.rpth.2024.102345. eCollection 2024 Jan.
9
Dual role of IL-21 in megakaryopoiesis and platelet homeostasis.白细胞介素-21在巨核细胞生成和血小板稳态中的双重作用。
Haematologica. 2017 Apr;102(4):637-646. doi: 10.3324/haematol.2016.143958. Epub 2017 Jan 5.
10
[Correlation between clinical outcome of 115 patients with idiopathic thrombocytopenic purpura and megakaryocyte counts in bone marrow biopsy].[115例特发性血小板减少性紫癜患者临床结局与骨髓活检巨核细胞计数的相关性]
Zhongguo Shi Yan Xue Ye Xue Za Zhi. 2011 Feb;19(1):202-6.

本文引用的文献

1
A modern overview of the process of platelet formation (thrombocytopoiesis) and its dependence on several factors.现代概述血小板形成(血小板生成)的过程及其对几个因素的依赖性。
Biochem Med (Zagreb). 2024 Oct 15;34(3):030503. doi: 10.11613/BM.2024.030503.
2
Thrombopoietin, the Primary Regulator of Platelet Production: From Mythos to Logos, a Thirty-Year Journey.血小板生成素,血小板生成的主要调节因子:从神话到理性,三十年的历程
Biomolecules. 2024 Apr 18;14(4):489. doi: 10.3390/biom14040489.
3
Essential thrombocythemia: 2024 update on diagnosis, risk stratification, and management.
原发性血小板增多症:2024 年诊断、风险分层和治疗更新。
Am J Hematol. 2024 Apr;99(4):697-718. doi: 10.1002/ajh.27216. Epub 2024 Jan 25.
4
Diversity of Megakaryocytes.巨核细胞的多样性。
Arterioscler Thromb Vasc Biol. 2023 Nov;43(11):2088-2098. doi: 10.1161/ATVBAHA.123.318782. Epub 2023 Sep 7.
5
The Application of Ethnomedicine in Modulating Megakaryocyte Differentiation and Platelet Counts.民族医学在调节巨核细胞分化和血小板计数中的应用。
Int J Mol Sci. 2023 Feb 5;24(4):3168. doi: 10.3390/ijms24043168.
6
The Application of Morphogo in the Detection of Megakaryocytes from Bone Marrow Digital Images with Convolutional Neural Networks.卷积神经网络在骨髓数字图像中巨核细胞检测中的 Morphogo 应用。
Technol Cancer Res Treat. 2023 Jan-Dec;22:15330338221150069. doi: 10.1177/15330338221150069.
7
The 5th edition of the World Health Organization Classification of Haematolymphoid Tumours: Myeloid and Histiocytic/Dendritic Neoplasms.世界卫生组织血液淋巴肿瘤分类第五版:髓系和组织细胞/树突状肿瘤。
Leukemia. 2022 Jul;36(7):1703-1719. doi: 10.1038/s41375-022-01613-1. Epub 2022 Jun 22.
8
The 5th edition of the World Health Organization Classification of Haematolymphoid Tumours: Lymphoid Neoplasms.《世界卫生组织造血与淋巴组织肿瘤分类》第五版:淋巴肿瘤。
Leukemia. 2022 Jul;36(7):1720-1748. doi: 10.1038/s41375-022-01620-2. Epub 2022 Jun 22.
9
Machine Learning of Bone Marrow Histopathology Identifies Genetic and Clinical Determinants in Patients with MDS.机器学习分析骨髓组织病理学鉴别 MDS 患者的遗传和临床决定因素
Blood Cancer Discov. 2021 Mar 22;2(3):238-249. doi: 10.1158/2643-3230.BCD-20-0162. eCollection 2021 May.
10
Cytomorphology of normal, reactive, dysmorphic, and dysplastic megakaryocytes in bone marrow aspirates.骨髓穿刺物中正常、反应性、异形和发育异常巨核细胞的细胞形态学。
Int J Lab Hematol. 2021 Jul;43 Suppl 1:23-28. doi: 10.1111/ijlh.13536.